Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An overview of rational design of mRNA-based therapeutics and vaccines
Kenneth K.W. To, William C. Cho
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 11, pp. 1307-1317
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 409
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Malgorzata Ewa Rogalska, Claudia Vivori, Juan Valcárcel
Nature Reviews Genetics (2022) Vol. 24, Iss. 4, pp. 251-269
Closed Access | Times Cited: 133
mRNA in the Context of Protein Replacement Therapy
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 67
Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci
Xiaozhu Zhang, Briana Van Treeck, Connor A. Horton, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 25
mRNA therapies: Pioneering a new era in rare genetic disease treatment
Guobo Shen, Jian Liu, Hanmei Yang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 696-721
Closed Access | Times Cited: 16
Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods
Andrew Webb, Emma N. Welbourne, Caroline A. Evans, et al.
Journal of Chromatography A (2025), pp. 465724-465724
Closed Access | Times Cited: 3
Key Considerations for a Prostate Cancer mRNA Vaccine
Guofu Lin, Ahmed Elkashif, Chayanika Saha, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104643-104643
Open Access | Times Cited: 2
Recent trends in RNA informatics: a review of machine learning and deep learning for RNA secondary structure prediction and RNA drug discovery
Kengo Sato, Michiaki Hamada
Briefings in Bioinformatics (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 39
mRNA therapeutics: New vaccination and beyond
Huanhuan Wei, Liangliang Zheng, Zefeng Wang
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 749-759
Open Access | Times Cited: 36
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact
Saber İmani, Oya Tagit, Chantal Pichon
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development
Emma N. Welbourne, Kate A. Loveday, Adithya Nair, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 9
Engineering EVs‐Mediated mRNA Delivery Regulates Microglia Function and Alleviates Depressive‐Like Behaviors
Kezhen Ge, Zetai Bai, Jiwei Wang, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 47
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 37
Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules
Jingjing Zhang, Yuheng Liu, Chao Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2182-2182
Open Access | Times Cited: 15
Path towards mRNA delivery for cancer immunotherapy from bench to bedside
Wenfei Chen, Yining Zhu, Jinhan He, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 96-115
Open Access | Times Cited: 14
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 13
mRNA-based therapeutic strategies for cancer treatment
Thilelli Taibi, Sehyun Cheon, Fabiana Perna, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2819-2834
Closed Access | Times Cited: 5
Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
Marı́a M. Lorenzo, Aitor Nogales, Kevin Chiem, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 19
Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines
Feng Lin, Emma Z. Lin, Misa Anekoji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Advances in RNA cancer therapeutics: New insight into exosomes as miRNA delivery
Luca Volpini, Federica Monaco, Lory Santarelli, et al.
Aspects of Molecular Medicine (2023) Vol. 1, pp. 100005-100005
Open Access | Times Cited: 11
The clinical progress and challenges of mRNA vaccines
Meng‐Zhen Yu, Nannan Wang, Jiaqing Zhu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 11
Development of Multi-epitope mRNA Vaccine against Clostridioides difficile Using Reverse Vaccinology and Immunoinformatics Approaches
Caixia Tan, Yuanyuan Xiao, Ting Liu, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 4, pp. 667-683
Open Access | Times Cited: 4
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top